San Diego-based Biolinq, a developer of continuous glucose monitoring sensors, said earlier this week that it has raised $100M in a Series B funding round. The funding was led by RiverVest Venture Partners
/PRNewswire/ Today, the RD Fund (Retinal Degeneration Fund) – the venture arm of the Foundation Fighting Blindness aimed at rapidly driving research toward.